Trade To Black Podcast: Christian Angermayer Bullish On Psychedelic Sector And Life Extension Technology May 22, 2022
Awakn Life Sciences Completes The World’s First Ketamine Treatment Study For Behavioral Addictions May 20, 2022
Awakn Life Sciences Completes World’s First Ketamine Treatment Study for a Range of Behavioral Addictions May 19, 2022
InMed Pharmaceuticals: Commercializing The Development Of Rare Cannabinoids For The Wellness Market May 18, 2022